Popp W, Wagner C, Merkle M, Reiser K, Kiss D, Zwick H
Abteilung für Atmungs- und Lungenkrankheiten, Krankenhaus der Stadt Wien-Lainz.
Wien Klin Wochenschr. 1993;105(13):377-81.
In the present study the incidence of bronchial asthma, airway complaints, and allergic rhinitis was investigated in a randomized population section including 3000 male and female inhabitants of Vienna (sex ratio 1:1), aged 20-44. Data on complaints in the respiratory tract were obtained from a total of 71% of the study population. Our results suggest that 14.7% of the entire population was suffering from allergic rhinitis (16.4% male versus 13.0% female; p < 0.05). Airway complaints such as wheezing, whistling, and feeling of tightness in the chest, awakening because of shortness of breath or cough were frequently reported, with no major differences between male and female subjects. The overall percentage of study subjects stating that they had suffered from airway complaints in the year before, i.e., the percentage of those giving affirmative answers to one of the questions, was 29%. Bronchial asthma was calculated to be present in 5.1% of the entire population (5.9 male versus 4.4 female). Attacks of asthma were reported by only 2.2% of the subjects, which gives an indication of the discrepancy between identified and unidentified bronchial asthma. Allergic rhinitis is correlated to, and constitutes a risk factor for the occurrence of complaints in the respiratory tract; public health policy should therefore be aimed at the prevention or early treatment of allergic rhinitis, and at reducing the proportion of cases suffering from unidentified bronchial asthma.
在本研究中,对维也纳3000名年龄在20 - 44岁之间的男女居民(性别比1:1)的随机抽样人群进行了支气管哮喘、气道不适及变应性鼻炎发病率的调查。呼吸道不适的数据来自于71%的研究人群。我们的结果表明,整个人口中14.7%患有变应性鼻炎(男性为16.4%,女性为13.0%;p < 0.05)。经常有喘息、哮鸣音及胸部紧绷感、因呼吸急促或咳嗽而惊醒等气道不适症状的报告,男女受试者之间无显著差异。表示在前一年曾出现气道不适症状的研究对象的总体百分比,即对其中一个问题给出肯定回答的人的百分比为29%。经计算,支气管哮喘在整个人口中的发病率为5.1%(男性为5.9%,女性为4.4%)。只有2.2%的受试者报告有哮喘发作,这表明已确诊和未确诊的支气管哮喘之间存在差异。变应性鼻炎与呼吸道不适的发生相关,并且是呼吸道不适发生的一个危险因素;因此,公共卫生政策应旨在预防或早期治疗变应性鼻炎,并减少未确诊支气管哮喘病例的比例。